These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer]. Ohkawa S Nihon Rinsho; 2006 Jan; 64 Suppl 1():198-202. PubMed ID: 16457249 [No Abstract] [Full Text] [Related]
10. Emerging drugs in pancreatic cancer. Ducreux M; Boige V; Malka D Expert Opin Emerg Drugs; 2004 May; 9(1):73-89. PubMed ID: 15155137 [TBL] [Abstract][Full Text] [Related]
11. [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives]. Murakami Y; Uemura K; Sudo T Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1661-9. PubMed ID: 21971141 [No Abstract] [Full Text] [Related]
12. [Adjuvant treatment of pancreatic cancer]. Oettle H Zentralbl Chir; 2003 May; 128(5):411-8. PubMed ID: 12813641 [TBL] [Abstract][Full Text] [Related]
13. Novel directions in neoadjuvant therapy for pancreas adenocarcinoma. Yang A; O'Reilly EM Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):585-601. PubMed ID: 25686370 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for pancreatic cancer: a time that has not yet come. Neifeld JP J Surg Oncol; 2007 Jun; 95(7):530-1. PubMed ID: 17192919 [No Abstract] [Full Text] [Related]
15. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266 [TBL] [Abstract][Full Text] [Related]
16. [Gemcitabine: a new chemotherapy agent for solid cancers]. Klastersky J; Awada A Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329 [TBL] [Abstract][Full Text] [Related]
17. [How I treat ... An advanced pancreatic cancer]. Polus M; Jerusalem G; Sautois B; Silvestre RM; Fillet G Rev Med Liege; 2002 Mar; 57(3):131-4. PubMed ID: 12014258 [TBL] [Abstract][Full Text] [Related]
18. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma? Kourie HR; Gharios J; Kattan J Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286 [No Abstract] [Full Text] [Related]
19. Chemoradiation protocols offer only incremental gains for pancreatic cancer patients. Bankhead C J Natl Cancer Inst; 2002 Nov; 94(22):1670-2. PubMed ID: 12441320 [No Abstract] [Full Text] [Related]